Candriam Equities L Oncology Fund Class BF Fonds
2.800,75
EUR
-1,00
EUR
-0,04
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 7,30% |
| AstraZeneca PLC | GB0009895292 | 4,27% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,19% |
| Novartis AG Registered Shares | CH0012005267 | 3,16% |
| Amgen Inc | US0311621009 | 3,16% |
| Thermo Fisher Scientific Inc | US8835561023 | 3,14% |
| Intuitive Surgical Inc | US46120E6023 | 3,11% |
| Roche Holding AG | CH0012032048 | 3,10% |
| Gilead Sciences Inc | US3755581036 | 3,01% |
| AbbVie Inc | US00287Y1091 | 2,96% |
| Sonstige | 63,61% |